US2022125819A1PendingUtilityA1
Methods of preventing and treating covid-19 infection
Est. expiryMar 23, 2040(~13.6 yrs left)· nominal 20-yr term from priority
Inventors:Sabine Hazan
A61K 31/4706A61K 33/30A61K 31/375A61P 31/14A61K 31/593A61K 31/7052
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A product for preventing COVID-19 infection in an individual, the product comprising a combination of hydroxychloroquine, vitamin C, vitamin D, and zinc. The combination comprises 1,000 mg to 10,000 mg of vitamin C, 3,000 IU to 40,000 IU of vitamin D, and 25 mg to 75 mg of zinc. The combination is administered daily for two or more days for prophylaxis, or the combination is administered weekly over a period of two or more weeks for prophylaxis.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A product for preventing COVID-19 infection in an individual, the product comprising a combination of:
a) hydroxychloroquine; b) vitamin C; c) vitamin D; and d) zinc.
2 . The product of claim 1 , wherein the combination is administered weekly over a period of two or more weeks for prophylaxis.
3 . The product of claim 1 , wherein the combination comprises:
a) 200 mg to 1,000 mg of hydroxychloroquine; b) 1,000 mg to 10,000 mg of vitamin C; c) 3,000 IU to 40,000 IU of vitamin D; and d) 25 mg to 75 mg of zinc; wherein the combination is administered daily for two or more days for prophylaxis.
4 . The product of claim 3 , wherein the combination is administered weekly over a period of two or more weeks for prophylaxis.
5 . The product of claim 1 , wherein the combination comprises:
a) 200 mg of hydroxychloroquine; b) 3,000 mg of vitamin C; c) 3,000 mg of vitamin D; and d) 50 mg of zinc.
6 . The product of claim 1 , wherein the combination comprises:
a) 400 mg of hydroxychloroquine; b) 3,000 mg of vitamin C; c) 3,000 mg of vitamin D; and d) 50 mg of zinc.
7 . The product of claim 2 , wherein the combination comprises:
a) 400 mg of hydroxychloroquine; b) 3,000 mg of vitamin C; c) 3,000 mg of vitamin D; and d) 50 mg of zinc.
8 . A product for preventing COVID-19 infection in an individual, the product comprising a combination of:
a) vitamin C; b) vitamin D; and c) zinc.
9 . The product of claim 8 , wherein the combination is administered weekly over a period of two or more weeks for prophylaxis.
10 . The product of claim 8 , wherein the combination comprises:
a) 1,000 mg to 10,000 mg of vitamin C; b) 3,000 IU to 40,000 IU of vitamin D; and c) 25 mg to 75 mg of zinc; wherein the combination is administered daily for two or more days for prophylaxis.
11 . The product of claim 10 , wherein the combination is administered weekly over a period of two or more weeks for prophylaxis.
12 . The product of claim 10 , wherein the combination comprises:
a) 3,000 mg of vitamin C; b) 3,000 mg of vitamin D; and c) 50 mg of zinc.
13 . The product of claim 8 , wherein the combination comprises:
b) 3,000 mg of vitamin C; c) 3,000 mg of vitamin D; and d) 50 mg of zinc.Join the waitlist — get patent alerts
Track US2022125819A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.